We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
526
Oracle
ORCL
$348B
– –
-2,950
Closed -$371K
ORI icon
527
Old Republic International
ORI
$10.4B
– –
-9,447
Closed -$290K
PAG icon
528
Penske Automotive Group
PAG
$14.2B
– –
-3,859
Closed -$625K
PBH icon
529
Prestige Consumer Healthcare
PBH
$2.41B
– –
-6,778
Closed -$492K
PEP icon
530
PepsiCo
PEP
$190B
– –
-1,909
Closed -$334K
PII icon
531
Polaris
PII
$4.2B
– –
-7,960
Closed -$797K
PLTR icon
532
Palantir
PLTR
$313B
– –
-15,350
Closed -$353K
PSN icon
533
Parsons
PSN
$6.36B
– –
-5,860
Closed -$486K
QDEL icon
534
QuidelOrtho
QDEL
$1.19B
– –
-348,000
Closed -$16.7M
RDNT icon
535
RadNet
RDNT
$4.89B
– –
-6,462
Closed -$314K
RL icon
536
Ralph Lauren
RL
$22.6B
– –
-1,903
Closed -$357K
RPAY icon
537
Repay Holdings
RPAY
$332M
– –
-43,439
Closed -$478K
RUN icon
538
Sunrun
RUN
$2.37B
– –
-14,319
Closed -$189K
S icon
539
SentinelOne
S
$6.34B
– –
-9,023
Closed -$210K
SABR icon
540
Sabre
SABR
$716M
– –
-45,982
Closed -$111K
SCI icon
541
Service Corp International
SCI
$11.5B
– –
-7,895
Closed -$586K
SF
542
Stifel
SF
$12.5B
– –
-4,970
Closed -$259K
SKYT icon
543
SkyWater Technology
SKYT
$1.56B
– –
-71,580
Closed -$728K
SNX icon
544
TD Synnex
SNX
$19.4B
– –
-7,188
Closed -$813K
SONO icon
545
Sonos
SONO
$1.86B
– –
-16,432
Closed -$313K
STRO icon
546
Sutro Biopharma
STRO
$395M
– –
-1,693
Closed -$95.6K
STT icon
547
State Street
STT
$50.6B
– –
-3,967
Closed -$307K
SUPN icon
548
Supernus Pharmaceuticals
SUPN
$2.76B
– –
-6,654
Closed -$227K
SWKS icon
549
Skyworks Solutions
SWKS
$9.39B
– –
-5,407
Closed -$586K
SWTX
550
DELISTED
SpringWorks Therapeutics
SWTX
– –
-1,283,176
Closed -$63.2M
20 21
22
23 24

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.